Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Neurology & Psychiatry
Filter     Order     Display # 
Date Item Title
02 Oct 2008 TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting with FDA for Tezampanel
02 Oct 2008 Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I
01 Oct 2008 Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound
30 Sep 2008 Astellas Submits an sNDA for the immunosuppressant Prograf (R) for Myasthenia Gravis in Japan
30 Sep 2008 Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
30 Sep 2008 Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS
28 Sep 2008 Takeda to Withdraw its Marketing Authorization Application for Ramelteon for the Treatment of Primary Insomnia in Europe
28 Sep 2008 CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
28 Sep 2008 Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
28 Sep 2008 Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
25 Sep 2008 UCB withdraws EU marketing authorisation application for lacosamide in diabetic neuropathic pain
23 Sep 2008 Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for its Transdermal Lidocaine
22 Sep 2008 Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin(R) for the Treatment of Multiple Sclerosis
22 Sep 2008 ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
22 Sep 2008 Five year data confirm that early treatment with Betaferon(R) at first sign of disease can delay progression to MS
22 Sep 2008 Merck KGaA: Results from IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients with Multiple Sclerosis
22 Sep 2008 Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease
22 Sep 2008 Acorda Therapeutics Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in Multiple Sclerosis
21 Sep 2008 Stem Cell Therapeutics Corp. Receives Letter from Health Canada and Verbal Request from FDA to Place a Clinical Hold on its REGENESIS Phase IIb Stroke Trial in Canada and the US, Respectively
21 Sep 2008 Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
21 Sep 2008 Data From MediciNova's Two-Year Phase II Clinical Trial of MN-166 in Multiple Sclerosis Presented At the World Congress for Treatment and Research in MS (WCTRIMS)
18 Sep 2008 AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
18 Sep 2008 Merck KGaA Announces Initiation Phase III Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
18 Sep 2008 Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
18 Sep 2008 S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
17 Sep 2008 Merck KGaA Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
17 Sep 2008 GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
17 Sep 2008 Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling
16 Sep 2008 AstraZeneca and Targacept Announce Top-Line Results From Phase IIb Study of AZD3480 in Alzheimer’s Disease
15 Sep 2008 Sangamo BioSciences Announces Presentation of Data From Diabetic Neuropathy Clinical Trials
15 Sep 2008 Keppra XR(TM) approved in the U.S.
15 Sep 2008 Lundbeck submits New Drug Application (NDA) for Serdolect® in the US for the treatment of schizophrenia
14 Sep 2008 Orion updates progress with dexmedetomidine trials
11 Sep 2008 Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program
11 Sep 2008 Glenmark to initiate Phase I studies for GBR 500 by filing its IND application with the US-FDA
11 Sep 2008 Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fribromyalgia
11 Sep 2008 Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
11 Sep 2008 Evotec Reports Start of Phase II Proof-of-Concept Quit Rate Study with EVT 302 and Results of Craving Study
11 Sep 2008 Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD
11 Sep 2008 PainCeptor Pharma announces positive clinical results that validate ASICs as novel targets for human pain
11 Sep 2008 Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
10 Sep 2008 Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDAä) Capsules at the American Academy of Pain Management Annual Clinical Meeting
10 Sep 2008 Better Tolerated Formulation of ADX10059 Reduces Acid Reflux
10 Sep 2008 Xel Pharmaceuticals Announces Successful Completion of Prototype Once-A-Week Huperzine A Transdermal Patch for Alzheimer's Disease
10 Sep 2008 Bayer Intensifies Research in Early Diagnosis of Alzheimer’s Disease
10 Sep 2008 Rexahn Pharmaceuticals Receives FDA Approval to Initiate Phase II Trial for Serdaxin in Patients with Major Depressive Disorders
09 Sep 2008 Oxford BioMedica Announces Promising Interim Phase I/II Results of Prosavin(R) in Parkinson's Disease
08 Sep 2008 Positive Sativex® Study Confirms Long Term Efficacy in MS Neuropathic Pain
07 Sep 2008 NeurAxon’s NXN-188 Demonstrates Pain Relief in Migraine with Aura
04 Sep 2008 NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex(R) Tablets
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 51 - 100 of 1619

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics